, Tracking Stock Market Picks
Enter Symbol:
Meridian Bioscience Inc. (VIVO) [hlAlert]

down 35.04 %

Meridian Bioscience Inc. (VIVO) rated Accumulate by CL King

Posted on: Tuesday,  May 13, 2008  8:25 AM ET by CL King

CL King rated Accumulate Meridian Bioscience Inc. (NASDAQ: VIVO) on 05/13/2008, when the stock price was $28.82. Since
then, Meridian Bioscience Inc. has lost 35.05% as of 01/20/2016's recent price of $18.72.
If you would have followed this CL King's recommendation on VIVO, you would have lost 35.04% of your investment in 2808 days.

Meridian Bioscience, Inc. is a fully-integrated life science company. The Company?s principal businesses are the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. It has three business segments: US Diagnostics, European Diagnostics and Life Science. The Company?s primary source of domestic and international revenues is core diagnostic products, which represented 83% of consolidated net sales during the fiscal year ended September 30, 2008 (fiscal 2008).

CL King research analysts "Discover the Uncovered." Our analysts seek out small- and mid-cap companies that may be ignored by other Wall Street research providers, identifying value and growth that may be unrecognized by institutional equity investors. Our goal is to generate superior absolute returns while minimizing downside risk.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2008 8:25 AM Buy
as of 12/24/2008
1 Week up  5.24 %
1 Month down  -6.72 %
3 Months down  -24.98 %
1 YTD down  -36.23 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy